ArticleInfectious Disease Modelling2021
Bertalanffy-Pütter models for the first wave of the COVID-19 outbreak.
Article in Infectious Disease Modelling, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A simple mathematical tool to forecast COVID-19 cumulative case numbers.Clinical epidemiology and global healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 pandemics challenges governments across the world. To develop adequate responses, they need accurate models for the spread of the disease. Using least squares, we fitted Bertalanffy-Pütter (BP) trend curves to data about the first wave of the COVID-19 pandemic of 2020 from 49 countries and provinces where the peak of the first wave had been passed. BP-models achieved excellent fits (R-squared above 99%) to all data. Using them to smoothen the data, in the median one could forecast that the final count (asymptotic limit) of infections and fatalities would be 2.48 times (95% confidence limits 2.42-2.6) and 2.67 times (2.39-2.765) the total count at the respective peak (inflection point). By comparison, using logistic growth would evaluate this ratio as 2.00 for all data. The case fatality rate, defined as the quotient of the asymptotic limits of fatalities and confirmed infections, was in the median 4.85% (confidence limits 4.4%-6.5%). Our result supports the strategies of governments that kept the epidemic peak low, as then in the median fewer infections and fewer fatalities could be expected.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.